Dahms Bradford D.
SEC CIK 1787307 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| JBIO | Jade Biosciences, Inc. | CFO | 37.8K | — | — | 1 | 2026-02-12 | 2026-02-12 |
Most active insiders at JBIO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Balta Elizabeth | See Remarks | — | — |
| 2 | Frohlich Tom | CEO, Dir | — | — |
| 3 | King Andrew James | See Remarks | — | — |
| 4 | Dahms Bradford D. | CFO | — | — |
| 5 | Fairmount Healthcare Fund II L.P. | Dir, 10% | — | — |
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-13 | 2026-02-12 | JBIO | Jade Biosciences, Inc. | Dahms Bradford D. | CFO | A - Grant | $0.00 | +37.8K | 37.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations